CU Gynecologic Oncology Research
@cugynonc.bsky.social
University of Colorado Anschutz gynecologic oncologists and researchers committed to advancing the future of women’s health. Focused on innovating early detection, prevention, and treatment through cutting-edge research. #GynOncology #CUAnschutz
Exciting news🎉 Courtney Bailey, a CU Anschutz Gates Institute Grubstake Award finalist and PhD student, will present her research "Macrophage Backpacks for Delivering Olaparib to #HGSCs" on Nov 20, 4–6 PM at CU Innovations Executive Conference Room in the AHSB. #CUGynOnc @courtneybailey.bsky.social
November 10, 2025 at 3:24 PM
Exciting news🎉 Courtney Bailey, a CU Anschutz Gates Institute Grubstake Award finalist and PhD student, will present her research "Macrophage Backpacks for Delivering Olaparib to #HGSCs" on Nov 20, 4–6 PM at CU Innovations Executive Conference Room in the AHSB. #CUGynOnc @courtneybailey.bsky.social
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa
#CUAnschutz #GynOnc
#CUAnschutz #GynOnc
November 5, 2025 at 9:39 PM
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa
#CUAnschutz #GynOnc
#CUAnschutz #GynOnc
CU Gynecologic Oncology was proud to join the HERA Ovarian Cancer Foundation’s Climb4Life & Gala! 🌄 Dr. Kian Behbakht spoke at the event & Taylor Benson, PhD, shared her HERA-funded research on WNT4 and metabolic biomarkers in #ovariancancer. 💙
For more information: bit.ly/3Lg6aMP
#CUAnschutz
For more information: bit.ly/3Lg6aMP
#CUAnschutz
October 30, 2025 at 2:52 PM
CU Gynecologic Oncology was proud to join the HERA Ovarian Cancer Foundation’s Climb4Life & Gala! 🌄 Dr. Kian Behbakht spoke at the event & Taylor Benson, PhD, shared her HERA-funded research on WNT4 and metabolic biomarkers in #ovariancancer. 💙
For more information: bit.ly/3Lg6aMP
#CUAnschutz
For more information: bit.ly/3Lg6aMP
#CUAnschutz
Join us for the Pharmacology Seminar Series as Dr. Elizabeth Woodruff discusses how chronic stress influences #HGSC progression and immune response through adrenergic signaling in the omentum. #OvarianCancer #GynOnc #CUAnschutz
Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
October 16, 2025 at 4:51 PM
Join us for the Pharmacology Seminar Series as Dr. Elizabeth Woodruff discusses how chronic stress influences #HGSC progression and immune response through adrenergic signaling in the omentum. #OvarianCancer #GynOnc #CUAnschutz
Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
✨Dr. Christine Walsh, a leading Gynecologic Oncologist at the University of Colorado Anschutz, recently appeared on 9News to discuss genetics' role in gyn cancers as well as share insights on ovarian cancer.
👉 Watch the full interviews here: bit.ly/3KNj0lv
#CancerGenetics #GynOc #CUAnschutz
👉 Watch the full interviews here: bit.ly/3KNj0lv
#CancerGenetics #GynOc #CUAnschutz
October 14, 2025 at 3:50 PM
✨Dr. Christine Walsh, a leading Gynecologic Oncologist at the University of Colorado Anschutz, recently appeared on 9News to discuss genetics' role in gyn cancers as well as share insights on ovarian cancer.
👉 Watch the full interviews here: bit.ly/3KNj0lv
#CancerGenetics #GynOc #CUAnschutz
👉 Watch the full interviews here: bit.ly/3KNj0lv
#CancerGenetics #GynOc #CUAnschutz
Thank you to all who attended the CU Ovarian Cancer Innovations Group (OCIG) Reception during the AACR Special Conference on #OvarianCancer! 💫 It was inspiring to connect with so many passionate researchers in Denver. Let’s keep the momentum going! #AACR #CUAnschutz
@uccc-gorg.bsky.social
@uccc-gorg.bsky.social
September 23, 2025 at 4:04 PM
Thank you to all who attended the CU Ovarian Cancer Innovations Group (OCIG) Reception during the AACR Special Conference on #OvarianCancer! 💫 It was inspiring to connect with so many passionate researchers in Denver. Let’s keep the momentum going! #AACR #CUAnschutz
@uccc-gorg.bsky.social
@uccc-gorg.bsky.social
Congrats to Dr. Liz Woodruff (Division of Repro Science) on receiving a $10K Cancer Innovation Pilot Grant from
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
September 23, 2025 at 3:00 PM
Congrats to Dr. Liz Woodruff (Division of Repro Science) on receiving a $10K Cancer Innovation Pilot Grant from
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
🎗️Attending the AACR Conference on Ovarian Cancer?
Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"
Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3
#AACRovca25
Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"
Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3
#AACRovca25
September 15, 2025 at 4:54 PM
🎗️Attending the AACR Conference on Ovarian Cancer?
Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"
Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3
#AACRovca25
Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"
Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3
#AACRovca25
Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer
August 18, 2025 at 6:14 PM
Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
August 11, 2025 at 4:48 PM
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
August 5, 2025 at 7:35 PM
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
July 31, 2025 at 8:26 PM
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
June 25, 2025 at 7:17 PM
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
Congrats to Team Bitler—Drs. Bitler, Corr, Sikora, Clauset, and many others—2025 CU ASPIRE Awardees🎉Their SPORE effort to advance ovarian cancer care with novel therapies & population science. #OvarianCancer #CUAnschutz @uccc-gorg.bsky.social @mjsikora.bsky.social View details here: Bit.ly/4mWBRsO
June 17, 2025 at 3:47 PM
Congrats to Team Bitler—Drs. Bitler, Corr, Sikora, Clauset, and many others—2025 CU ASPIRE Awardees🎉Their SPORE effort to advance ovarian cancer care with novel therapies & population science. #OvarianCancer #CUAnschutz @uccc-gorg.bsky.social @mjsikora.bsky.social View details here: Bit.ly/4mWBRsO
Congratulations to Courtney Bailey, PhD student in Biomedical Engineering at CU Boulder and part of the Gynecologic Oncology Research Group at CU Anschutz! She was awarded the Achievement Reward for College Scientist Scholarship. Well deserved! 👏 #CUAnschutz #CUBoulder #BiomedicalEngineering #GynOnc
June 11, 2025 at 6:40 PM
Congratulations to Courtney Bailey, PhD student in Biomedical Engineering at CU Boulder and part of the Gynecologic Oncology Research Group at CU Anschutz! She was awarded the Achievement Reward for College Scientist Scholarship. Well deserved! 👏 #CUAnschutz #CUBoulder #BiomedicalEngineering #GynOnc
Join Computational Bioscience (CPBS) Program student Weishan Li for a talk on "Deriving Cell Type Specific Expression Profiles from HGSC using BuDDI"
Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...
#OvarianCancer #GynOnc #CUAnschutz
Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...
#OvarianCancer #GynOnc #CUAnschutz
May 20, 2025 at 2:14 PM
Join Computational Bioscience (CPBS) Program student Weishan Li for a talk on "Deriving Cell Type Specific Expression Profiles from HGSC using BuDDI"
Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...
#OvarianCancer #GynOnc #CUAnschutz
Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...
#OvarianCancer #GynOnc #CUAnschutz
Join Human Medical Genetics and Genomics Program (HMGGP) student Samantha Lopez Alvarez for a talk on "Evaluating Expression Based HRD Predictors in Black and White HGSC Patients"
When 📅: Today (5/15/2025) 1PM – 2:30PM MST
When📍: #CUAnschutz Hensel Phelps West Auditorium
#OvarianCancer
When 📅: Today (5/15/2025) 1PM – 2:30PM MST
When📍: #CUAnschutz Hensel Phelps West Auditorium
#OvarianCancer
May 15, 2025 at 2:42 PM
Join Human Medical Genetics and Genomics Program (HMGGP) student Samantha Lopez Alvarez for a talk on "Evaluating Expression Based HRD Predictors in Black and White HGSC Patients"
When 📅: Today (5/15/2025) 1PM – 2:30PM MST
When📍: #CUAnschutz Hensel Phelps West Auditorium
#OvarianCancer
When 📅: Today (5/15/2025) 1PM – 2:30PM MST
When📍: #CUAnschutz Hensel Phelps West Auditorium
#OvarianCancer
Today is World Ovarian Cancer Day #WOCD! In recognition of this important day, the CU Division of GynOnc will once again sponsor and participate in Jodi’s Race for Awareness 5k to support gyn cancers, including ovarian cancer, on 6/14/2025 in Denver. To register, please visit www.JodisRace.org
May 8, 2025 at 2:01 PM
Today is World Ovarian Cancer Day #WOCD! In recognition of this important day, the CU Division of GynOnc will once again sponsor and participate in Jodi’s Race for Awareness 5k to support gyn cancers, including ovarian cancer, on 6/14/2025 in Denver. To register, please visit www.JodisRace.org
High-Grade Serous Carcinoma of the ovary, fallopian tube or peritoneum has the worst prognosis due to late diagnosis and therapy resistance. Dr. Alan Elder from the CU #GynOnc Lab aims to uncover the role of SEMA7A in therapy resistance and immunoevasion in ovarian cancer! @uccc-gorg.bsky.social
April 29, 2025 at 3:07 PM
High-Grade Serous Carcinoma of the ovary, fallopian tube or peritoneum has the worst prognosis due to late diagnosis and therapy resistance. Dr. Alan Elder from the CU #GynOnc Lab aims to uncover the role of SEMA7A in therapy resistance and immunoevasion in ovarian cancer! @uccc-gorg.bsky.social
🔬Curious about gynecologic cancer research but not a science expert? Join CU DRS & CGCA’s new virtual, quarterly series making cutting-edge research easy to understand @uccc-gorg.bsky.social
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
April 22, 2025 at 8:15 PM
🔬Curious about gynecologic cancer research but not a science expert? Join CU DRS & CGCA’s new virtual, quarterly series making cutting-edge research easy to understand @uccc-gorg.bsky.social
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
The CU Medical Scientist Training Program (MSTP) Annual Retreat was held on 4/18/2025. Scott Lin presented his research findings on targeting the epigenetic environment of therapy-resistant ovarian cancer, and Raquel Ortega presented her exciting research on Alt-EJ and PARP inhibitors. #CUAnschutz
April 21, 2025 at 2:17 PM
The CU Medical Scientist Training Program (MSTP) Annual Retreat was held on 4/18/2025. Scott Lin presented his research findings on targeting the epigenetic environment of therapy-resistant ovarian cancer, and Raquel Ortega presented her exciting research on Alt-EJ and PARP inhibitors. #CUAnschutz
High-grade serous carcinoma is a tough ovarian cancer to treat and often recurs after chemotherapy. Dr. Marjon recently resubmitted a paper showing that targeting certain tumor immune cells could help make treatments like chemotherapy more effective. Wishing her luck🤞 #HGSC #CUAnschutz #GynOnc
April 15, 2025 at 5:55 PM
High-grade serous carcinoma is a tough ovarian cancer to treat and often recurs after chemotherapy. Dr. Marjon recently resubmitted a paper showing that targeting certain tumor immune cells could help make treatments like chemotherapy more effective. Wishing her luck🤞 #HGSC #CUAnschutz #GynOnc
Momie Yamamoto and Ritz Iwanaga from Dr. Bitler's lab at CU Anschutz recently submitted a paper showing that Chromobox2 (CBX2) plays a role in driving HGSC progression. This suggests a potential new treatment option for HGSC patients. Wish them luck publishing their paper #HGSC #GynOnc #CUAnschutz
March 26, 2025 at 2:58 PM
Momie Yamamoto and Ritz Iwanaga from Dr. Bitler's lab at CU Anschutz recently submitted a paper showing that Chromobox2 (CBX2) plays a role in driving HGSC progression. This suggests a potential new treatment option for HGSC patients. Wish them luck publishing their paper #HGSC #GynOnc #CUAnschutz
Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz
March 19, 2025 at 3:09 PM
Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz
Join us for Scott Lin’s thesis update on "Stimulating Innate Immunity in High-Grade Serous Ovarian Cancer via EHMT1/2 Inhibition". Scott is a Doctoral Candidate in the CU Cancer Bio Program and Dr. Bitler’s Lab.
🗓️3/13/2025 10:30-11:30AM
📍CU Anschutz - Hensel Phelps East
#OvarianCancer #CUDRS
🗓️3/13/2025 10:30-11:30AM
📍CU Anschutz - Hensel Phelps East
#OvarianCancer #CUDRS
March 12, 2025 at 6:43 PM
Join us for Scott Lin’s thesis update on "Stimulating Innate Immunity in High-Grade Serous Ovarian Cancer via EHMT1/2 Inhibition". Scott is a Doctoral Candidate in the CU Cancer Bio Program and Dr. Bitler’s Lab.
🗓️3/13/2025 10:30-11:30AM
📍CU Anschutz - Hensel Phelps East
#OvarianCancer #CUDRS
🗓️3/13/2025 10:30-11:30AM
📍CU Anschutz - Hensel Phelps East
#OvarianCancer #CUDRS